Results 111 to 120 of about 66,503 (250)
Finding the elusive and causative autoantibody: An atypical case of autoimmune hemolytic anemia [PDF]
, 2015 Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/111227/1/ccr3203 ...
Clark D. A. +3 more
core +1 more source
American journal of hematology/oncology, 2019 Immune checkpoint inhibitors (ICPis) are a novel class of immunotherapeutic agents that have revolutionized the treatment of cancer; however, these drugs can also cause a unique spectrum of autoimmune toxicity.
R. K. Leaf +17 more
semanticscholar +1 more source
Autoimmune Hemolytic Anemia in Chronic Myeloid Leukemia
Pharmacology, 2020 Background: Autoimmune hemolytic anemia (AIHA) might be associated with underlying hematological malignancies such as chronic lymphocytic leukemia. However, the association between AIHA and chronic myelogenous leukemia is extremely unusual.
Tahseen Hamamyh, M. Yassin
semanticscholar +1 more source
Management of autoimmune hemolytic anemia in children and adolescents: A single center experience [PDF]
, 2011 Objective: To present and discuss the treatment of autoimmune hemolytic anemia (AIHA). Materials and Methods: The medical records of all patients (n=19) diagnosed in a tertiary hematology center between 1999 and 2010 were retrospectively reviewed.Results:
Emine Zengin +3 more
core
Journal of clinical apheresis, 2020 We performed a systematic review and meta‐analysis to evaluate the efficacy and safety of therapeutic plasma exchange (TPE) in adult patients with autoimmune hemolytic anemia (AIHA).
Jiawen Deng +4 more
semanticscholar +1 more source
MedComm, Volume 7, Issue 2, February 2026.Tumor‐associated macrophages are the most abundant immune cells in the tumor microenvironment, driving malignant progression and treatment resistance. This review summarizes the protumor mechanisms of TAMs (including phagocytosis modulation, metabolic reprogramming, exosomal communication, and immune interactions), evaluates three major strategies ...
Wurihan Bao +8 more
wiley +1 more source
Paraneoplastic autoimmune hemolytic anemia in ovarian cancer: a marker of disease activity
Rare Tumors, 2015 Autoimmune hemolytic anemia (AIHA) is a rare paraneoplastic syndrome associated with ovarian malignancies. We report a case of a 77 year-old female with metastatic ovarian carcinoma who presented with worsening anemia from her baseline, and was found to ...
Kah Poh Loh +4 more
doaj +1 more source
Haematologica, 2020 Citation: Bruno Fattizzo, Marc Michel, Anna Zaninoni, Juri Giannotta, Stephanie Guillet, Henrik Frederiksen, Josephine M.I. Vos, Francesca R. Mauro, Bernd Jilma, Andrea Patriarca, Francesco Zaja, Anita Hill, Sigbiørn Berentsen, and Wilma Barcellini ...
B. Fattizzo +13 more
semanticscholar +1 more source
Stem Cell Therapy for Inflammatory Diseases: Progress, Challenges, and Future Directions
MedComm, Volume 7, Issue 2, February 2026.Stem cells offer multifaceted therapeutic approaches for inflammatory diseases, each exhibiting distinct therapeutic properties. Hematopoietic stem cells, primarily through hematopoietic stem cell transplantation (HSCT), can effectively remodel the immune environment, showing particular promise in treating genetically linked cases.
Chen Wu +4 more
wiley +1 more source
Marked efficacy of Rituximab in multifocal motor neuropathy associated with chronic lymphocytic leukemia [PDF]
, 2016 The authors describe a patient who presented a multifocal motor neuropathy (MMN) associated with a high anti-ganglioside antibody (anti-GM1 and anti-GD1) titer at the clinical onset of a B-cell chronic lymphocytic leukemia (B-CLL). Immunomodulation (IVIg
Antonella Di, Pasquale +6 more
core